Table 1 Clinical data of the study participants
From: Predictive value of cyst/tumor volume ratio of pituitary adenoma for tumor cell proliferation
Variables | Value |
|---|---|
Median age, years (IQR) | 53.90 (16.46–81.46) |
Number of female patients (%) | 32 (42.67) |
Median cyst volume (IQR) (cm3) | 0.366 (0.084–1.796) |
Median tumor volume (IQR) (cm3) | 4.573 (1.849–8.790) |
Median C/T ratio (IQR) | 0.187 (0.018–0.570) |
Number of microadenomas (maximum diameter, < 1 cm) | 1 (1.4) |
Number of macroadenomas (maximum diameter, 1–3 cm) | 63 (87.5) |
Number of giant adenomas (maximum diameter, ≥ 4 cm) | 8 (11.1) |
Knosp grade (n [%]) | |
 0 | 12 (16.7) |
 1 | 19 (26.4) |
 2 | 13 (18.1) |
 3 | 10 (13.9) |
 4 | 18 (25.0) |
IHC classification (n [%]) | |
 ACTH | 12 (16.7) |
 FSH | 6 (8.3) |
 GH | 1 (1.4) |
 LH | 25 (34.72) |
 Multiple hormone type | 7 (9.7) |
 Null | 11 (15.2) |
 PRL | 10 (13.9) |
Percentage of patients with Ki67 index of ≥ 3% (n [%]) | 25 (34.72) |
Percentage of patients with nuclear atypia (n [%]) | 28 (38.89) |